The success and recent expansion of a pioneering AF virtual ward project in Leicester could prevent thousands of hospital ...
The NyokAssist device, from China, had few adverse outcomes by 30 days. More devices—and more trials—are on the way.
In a randomized trial, adding an antiplatelet to anticoagulant therapy in patients with ischemic stroke, nonvalvular atrial fibrillation, and atherosclerosis provided no significant benefit. There was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback